Jianke
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Jianke (健客, 'healthy guest') is a Chinese online B2C pharmacy and healthcare services platform founded in 2006 in Guangzhou. It obtained the Internet drug B2C transaction license in 2009 — the first licensed online pharmacy in Guangdong — and now holds the full set of A+B+C pharmaceutical distribution licenses. With over 680,000 SKUs and more than 100 million cumulative customers, it focuses on chronic-disease management with e-prescriptions and physician consultations. It raised $50 million in a 2017 Series A+ and $130 million in a 2021 Series B led by GTJA Investment Group, valued at $500–600 million. No failure event is on record.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founding and first license
Jianke is founded in Guangzhou in 2006; in 2009 it becomes the first licensed online pharmacy in Guangdong with the Internet drug B2C transaction license.
- $50M Series A+
Jianke raises $50 million in a Series A+ round from Asia-Pac eCommerce, PGA Ventures and Volcanics Capital.
- $130M Series B
Jianke raises $130 million in Series B financing led by GTJA Investment Group with HBM Healthcare Investments and Crescent Point, valued at $500–600 million.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.